Chemed Corporation
NYSE:CHEMedical - Care Facilities
+$4.91 today
- Market cap
- $7.12B
- Beta
- 0.54
- P/E (TTM)
- 23.2
- EPS (TTM)
- $19.00
- Dividend yield
- 0.54%
Volume 0.17M
Average 0.25M
CHE Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Chemed CorporationNYSE: CHE
Common Stock · Q2 FY2026 · quarter ended Jun 2026
Common stock broadly unchanged from a year ago
Common stock stood at $37.61M at the end of Q2 FY2026, up 0.1% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +0.7% a year.
Context
- Common stock amounted to 2.4% of total assets at the end of Q2 FY2026, up 0.2 pp from a year earlier.
- Common stock increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 37.6M USD
- Year-over-year change
- +0.5%
- 4-year CAGR
- +0.7%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 37.6M | +0.5% |
| FY2024 | 2024-12-31 | 37.42M | +0.6% |
| FY2023 | 2023-12-31 | 37.18M | +1.1% |
| FY2022 | 2022-12-31 | 36.8M | +0.8% |
| FY2021 | 2021-12-31 | 36.51M | — |
Common Stock vs competitors
How CHE compares with its peers on the latest reported figures
- CHE's Jun 2026 common stock of $37.61M is the highest of the 5 companies compared; the peer median is $27K.
- Its year-over-year change of +0.1% is the 3rd highest of 5, against a peer median of +2.3%.
- Common stock amounts to 2.4% of total assets for CHE, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $37.61M | +0.1% | +0.7% | 2.4% | |
| Oct 2026 | $2.18M | +4.5% | +3.8% | 0.1% | |
| Mar 2026 | $35K | +0.0% | +6.5% | 0.0% | |
| Jun 2026 | $19K | +5.6% | +4.0% | 0.0% | |
| Sep 2026 | $18K | +0.0% | +0.0% | 0.0% | |
| Peer median (excluding CHE) | $27K | +2.3% | +3.9% | 0.0% | |
Competitors are the stored peer set for CHE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 32.9M | 74.13M | 263.96M | 178.35M | 74.52M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 137.22M | 139.41M | 181.51M | 171.16M | 182.58M |
| Inventory | 10.11M | 10.27M | 12M | 8.19M | 7.54M |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 230.29M | 272.61M | 500.84M | 394.75M | 302.62M |
| Property, Plant & Equipment (Net) | 318.73M | 335.38M | 330.23M | 328.16M | 336.81M |
| Goodwill | 578.59M | 581.3M | 585.02M | 666.74M | 667M |
| Intangible Assets | 108.1M | 99.73M | 90.26M | 92.21M | 82.76M |
| Long-term Investments | 98.88M | 0 | 0 | 0 | 140.35M |
| Tax Assets | 0 | 0 | 0 | 0 | 101.82M |
| Other Non-current Assets | 8.14M | 153M | 161.74M | 186.72M | 8.65M |
| Total Non-current Assets | 1.11B | 1.17B | 1.17B | 1.27B | 1.34B |
| Total Assets | 1.34B | 1.44B | 1.67B | 1.67B | 1.64B |
| Account Payables | 73.02M | 41.88M | 64.03M | 44.15M | 53.46M |
| Short-term Debt | 0 | 5M | 15.7M | 0 | 51.89M |
| Tax Payables | 41K | 18.52M | 6.86M | 7.59M | 11.17M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 134.63M | 145.84M | 121.87M | 134.75M | 120.95M |
| Total Current Liabilities | 302.4M | 297.21M | 312.05M | 285.7M | 287.13M |
| Long-term Debt | 185M | 92.5M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 23.18M | 38.61M | 30.32M | 25.95M | 121.14M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 136.14M |
| Other Non-current Liabilities | 108.24M | 104.47M | 117.07M | 139.4M | 13.34M |
| Total Non-current Liabilities | 417.05M | 346.09M | 248.17M | 263.89M | 373.48M |
| Total Liabilities | 719.45M | 643.3M | 560.22M | 549.58M | 660.61M |
| Common Stock | 36.51M | 36.8M | 37.18M | 37.42M | 37.6M |
| Retained Earnings | 1.97B | 2.2B | 2.45B | 2.72B | 2.96B |
| Accumulated OCI | 0 | 0 | 0 | 0 | 2.36M |
| Other Stockholders Equity | 2.2M | 2.25M | 2.08M | 2.22M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 623.27M | 798.72M | 1.11B | 1.12B | 979.41M |
| Total Debt | 323.54M | 247.01M | 155.11M | 140.84M | 154.76M |
| Net Debt | 290.65M | 172.88M | (108.85M) | (37.51M) | 80.24M |
Chemed Corporation
NYSE:CHE
Intrinsic Alpha fair value
Locked
Current Price
$546.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.